ESSEX WOODLANDS HEALTH VENTURES FUND V LP 4
4 · ACURA PHARMACEUTICALS, INC · Filed Oct 4, 2012
Insider Transaction Report
Form 4
Transactions
- Other
Common Stock
2012-10-01+9,622,335→ 9,781,985 total - Other
Common Stock Warrants (right to buy)
2012-10-01+502,901→ 512,901 totalExercise: $3.40From: 2007-08-20Exp: 2014-08-20→ Common Stock (502,901 underlying)
Footnotes (1)
- [F1]1. On November 3, 2005, Galen Partners III, LP, et al ("Galen"), Care Capital Investments II, L.P., et al ("Care Capital"), and Essex Woodlands Health Ventures V, L.P. ("Essex") entered into an Operating Agreement, whereby each of such entities contributed all shares owned by each of such entities in Acura Pharmaceuticals, Inc. ("Acura") to GCE Holdings LLC ("GCE"). The members of GCE dissolved GCE effective October 1, 2012, with the result that all remaining shares of Acura and warrants to purchase shares of Acura held by GCE were distributed to the members. The number of shares of common stock and warrants to purchase shares of common stock of Acura represented on this Form 4 as being acquired by Essex represents the shares of common stock and warrants to purchase shares of common stock of Acura received by Essex from such distribution.